115 related articles for article (PubMed ID: 6748044)
1. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
Watanabe M; Tsuru S; Aiso S; Hibi T; Yoshida T; Asakura H; Zinnaka Y; Tsuchiya M
J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
[TBL] [Abstract][Full Text] [Related]
2. Demonstration and characterization of immunosuppressive factors in sera from patients with Crohn's disease.
Watanabe M; Tsuru S; Zinnaka Y; Yoshida T; Aiso S; Hibi T; Asakura H; Tsuchiya M
J Clin Lab Immunol; 1985 May; 17(1):13-9. PubMed ID: 4045994
[TBL] [Abstract][Full Text] [Related]
3. Studies of cell-mediated immunity in patients with Crohn's disease.
Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
[TBL] [Abstract][Full Text] [Related]
4. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
[TBL] [Abstract][Full Text] [Related]
5. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
6. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
[TBL] [Abstract][Full Text] [Related]
7. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype.
Matsuda T; Suzuki J; Furuya K; Masutani M; Kawakami Y
Am J Gastroenterol; 2001 Sep; 96(9):2705-10. PubMed ID: 11569699
[TBL] [Abstract][Full Text] [Related]
8. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
Goodacre RL; Bienenstock J
Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
[TBL] [Abstract][Full Text] [Related]
9. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
10. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
11. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
12. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
14. The circulating common gamma chain (CD132) in inflammatory bowel disease.
Nielsen OH; Kirman I; Johnson K; Giedlin M; Ciardelli T
Am J Gastroenterol; 1998 Mar; 93(3):323-8. PubMed ID: 9517632
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic response and interleukin 2 production in Crohn's disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
[TBL] [Abstract][Full Text] [Related]
18. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
19. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
Dopp AC; Mutchnick MG; Goldstein AL
Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.
Reinisch W; Gasché C; Tillinger W; Wyatt J; Lichtenberger C; Willheim M; Dejaco C; Waldhör T; Bakos S; Vogelsang H; Gangl A; Lochs H
Am J Gastroenterol; 1999 Aug; 94(8):2156-64. PubMed ID: 10445543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
